Download Case Conference: A Zebra Like Cystic Fibrosis

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Western States Pediatric
Pulmonary Case Conference
Cough, Hypoxia, and
Down Syndrome
Emily DeBoer, MD
The Children’s Hospital
University of Colorado
September 22, 2010
Outline




Case presentation: Cough, Hypoxia, and Down
Syndrome
Differential Diagnosis
Multi-system complications of patients with
Trisomy 21
Treatment and Monitoring
Chief Complaint

9 month old female with Down Syndrome
referred to pulmonary clinic for initial evaluation
because of cough and persistent oxygen
requirement
History of Present Illness
Daily cough for months - day and night
 No increased work of breathing
 Snoring
 Gags with jejunal feeds

 Treated
with Ranitidine
 Severe oral aversion, tastes by mouth
Past medical/surgical history
Trisomy 21
 Born at 36 weeks in Colorado
 Esophageal atresia without TEF

 GT
placment DOL 1
 Gastric pull-through at 4 months
On and off oxygen
 Ventilated x 1 week after surgery
 Discharged at 5 months on ¼ lpm O2 via
nasal cannula

PMH/PSH
PDA ligation at 5 months of age
 Recent echo revealed – “normal function,
small left to right ASD, mild TR”
 Monthly esophageal dilations – tolerated
well

Meds at visit





Ranitidine
Spironolactone/hydrochlorothiazide
¼ lpm oxygen
No inhaled medicines
No steroids
Review of Systems








No fevers
Adequate growth
No hemoptysis
No vomiting
No steatorrhea
Normal thyroid
No hematuria
Sitting with support
Family and Social History

No asthma, allergies, or lung disease in the
family

Lives with mom, “adopted grandparents” in
Denver
Parents are from Senegal
No known TB exposures
No pets
No smokers




Physical Exam

Vitals HR 136 | RR 28 | Ht 65 cm (43%) | Wt 7.5
kg (39%)
 SaO2







88% RA | SaO2 95% ¼ lpm
General: happy baby, + drooling
HEENT: Down’s facies, small nares, +rhinorrhea
Chest: Easy work of breathing, clear to
auscultation, prolonged expiratory phase
CVS: RRR, normal S1 and S2, no murmur
Abd: Soft, non-tender, no hepatosplenomegaly
Ext: No clubbing
Neuro: Decreased truncal tone
Chest Xray at 8 months of age
What should we do?
What should we do?
Differential Diagnosis – cough, hypoxia
 Reflux / aspiration
 Pulmonary edema
 Airway anomaly / poor airway clearance
 Asthma
 Interstitial lung disease
 Pneumonia/infection
What should we do?
Differential Diagnosis – cough, hypoxia






Reflux / aspiration
Pulmonary edema
Airway anomaly / poor airway clearance
Asthma
Interstitial lung disease
Pneumonia/infection
Because of her Down Syndrome, she is at risk for
aspiration, heart disease, tracheal anomalies, obstructive
sleep apnea, pulmonary hypertension
Bronchoscopy



Erythematous mucosa
Copious clear secretions
Mild-mod malacia of trachea and both mainstem bronchi
COLOR
CHARACTER
NUCLEATED CELLS
RBC
RBC MORPH
SEGS
LYMPHS
MONOCYTES
MACROPHAGES


COLORLESS
HAZY
910
1705
NORMAL
55
18
7
17
LIPID INDEX = 0.
IRON INDEX = 270.
Bacterial and viral cultures: negative
What should we do now?

Cause of increased iron index?

Treatment?
Disorders with pulmonary capillaritis
 Disorders without pulmonary capillaritis

 Noncardiovascular
 Cardiovascular
Chronic heart failure
 Pulmary Hypertension
 Pulmonary veno-occlusive disease

Follow-up via phone

New symptoms
 Rhinorrhea
 Increased
cough, respiratory rate
 Sleeping more
 Requiring ½ - 1 lpm O2

Intervention
5
days of oral steroids
Follow-up
Outpatient echocardiogram scheduled
 Improved for 2 weeks, then symptoms
returned
 Treated with 5 more days oral steroids by
her PCP
 Symptoms do not resolve – present to ED
 Further history – taking liquids by mouth
for 6 weeks as instructed by therapy

Physical Exam in ED






Vitals HR 180 | RR 62 | SaO2 94% 3 lpm
General: Infant in moderate respiratory distress
HEENT: Down’s facies, +rhinorrhea
Chest: Subcostal retractions, tachypneic,
coarse symmetric breath sounds
CVS: Tachycardic, prominent S2, 2/6 systolic
flow murmur at LLSB
Abd: Soft, non-tender, Liver down 3 cm
8 months of age
12 months of age in ED
What should we do?
What should we do?
Differential Diagnosis – cough, hypoxemia,
prominent S2, hepatomegaly
 Pulmonary hypertension
 Aspiration
 Heart failure
 Infection
Laboratory

CBC
 11.6
WBC 81% Segs, 8% Lymphs, 10% Monos
 Hb 16.3 g/dL / Hct 51.4 %
 Platelets 221

CBG
 pH
7.43
 CO2 34 mm Hg
Echocardiogram




Small secundum ASD with bidirectional flow.
Moderate right heart enlargement and moderate
septal flattening.
Normal left ventricular size and systolic function.
Low normal RV systolic function.
Systemic pulmonary hypertension (on 3 lpm NC
O2).
 TV jet 4.48 m/second
 RV-RA grad 80 mm Hg (SBP 90/69)
Pulmonary Hypertension

Causes?
Pulmonary Hypertension

Causes of secondary PAH
 Cardiac/Vascular
anomaly
 Chronic lung disease
 Trisomy 21
 Aspiration / reflux
 Overcirculation from PDA (repaired at 5 months)
 Obstructive sleep apnea
 Thromboembolic disease
 Collagen vascular disease
 Thyroid disease
 HIV
Pulmonary Hypertension

Causes of secondary PAH
 Cardiac/Vascular
anomaly
 Chronic lung disease
 Trisomy 21
 Aspiration / reflux
 Overcirculation from PDA (repaired at 5 months)
 Obstructive sleep apnea
 Thromboembolic disease
 Collagen vascular disease
 Thyroid disease
 HIV
Cardiac catheterization
30% FiO2
Qp/Qs = 1.25:1; Rp/Rs = 0.46
21% FiO2
Qp/Qs = 1.25:1; Rp/Rs = 0.64
100% FiO2 with 40 ppm iNO
Qp/Qs = 1.14:1; Rp/Rs = 0.47
Pulmonary Hypertension

Causes of secondary PAH
 Cardiac/Vascular
anomaly
 Chronic lung disease
 Trisomy 21
 Aspiration / reflux
 Overcirculation from PDA (repaired at 5 months)
 Obstructive sleep apnea
 Thromboembolic disease
 Collagen vascular disease
 Thyroid disease
 HIV
Chest CT
Chest CT - prone
Esophagram
•Thread-like appearance of
distal esophagus
•Fundus of stomach superior to
the diaphragm
•No normal peristalsis –
movement of feeds only with
gravity
Swallow study
•Deep laryngeal penetration with thin liquids.
•No aspiration with pureeds.
Pulmonary Hypertension

Causes of secondary PAH
 Cardiac/Vascular
anomaly
 Chronic lung disease
 Trisomy 21
 Aspiration / reflux
 Overcirculation from PDA (repaired at 5 months)
 Obstructive sleep apnea
 Thromboembolic disease
 Collagen vascular disease
 Thyroid disease
 HIV
Polysomnogram





Mild sleep-disordered
breathing
Apnea-hypopnea
index of 3 events/hour
SpO2 in low 80s in RA
SpO2 in mid 90s on
¼ lpm NC
(≥92% for 99% of TST)
Obstructive Sleep Apnea does not explain PAH
Pulmonary Hypertension

Causes of secondary PAH
 Cardiac/Vascular
anomaly
 Chronic lung disease
 Trisomy 21
 Aspiration / reflux
 Overcirculation from PDA (repaired at 5 months)
 Obstructive sleep apnea
 Thromboembolic disease
 Collagen vascular disease
 Thyroid disease
 HIV
Further laboratories
Protein C and S
 Prothrombin
 Antithrombin III
 Lupus Anticoagulant
 Factor V Leiden
 Homocysteine
 Beta 2 GP1 (antiphospholipid) antibodies
 Cardiolipin IgG and IgM

Pulmonary Hypertension

Causes of secondary PAH
 Cardiac/Vascular
anomaly
 Chronic lung disease
 Trisomy 21
 Aspiration / reflux
 Overcirculation from PDA (repaired at 5 months)
 Obstructive sleep apnea
 Thromboembolic disease
 Collagen vascular disease
 Thyroid disease
 HIV
Further laboratories
ANA, ESR, CRP
 TSH and free T4
 HIV

Treatment of PAH –
Vasodilation and Diuretics
Continuous oxygen
 Oral Sildenafil – started at 0.5 mg/kg/dose
and titrated to 2 mg/kg/dose q6h
 Furosemide 1 mg/kg/dose TID

Thromboembolic disease can
contribute to PAH
Elevated Beta 2 GP1 antibodies and low
antithrombin III
 Discussed aspirin or coumadin therapy

Patient’s Echo Changes with
Therapy
Date of
Echo
Oxygen use
via nasal
cannula
RV-RA gradient
(calculated from TR
jet)
Degree of
septal
flattening
Right heart
enlargement
Week 0
3 lpm
80 mm Hg
Moderate
Moderate
Week 1
1 lpm
60 mm Hg
Moderate
Moderate
Week 2
½ lpm / off
50 mm Hg / 70 mm
Hg
Mild /
Moderate
Mild
Week 6
½ lpm
Unable to estimate;
no TR jet
Normal
geometry
None
Conclusions

Cause of Pulmonary Hypertension
 Chronic
lung disease
Primary Aspiration
 Trisomy 21
 Overcirculation prior to PDA closure

 ?Thromboembolic

disease
Cause of increased iron index
 Pulmonary
Hypertension
Conclusions

Cause of her hypoxia
 Pulmonary
hypertension
 Chronic lung disease

Cause of her cough
 Chronic
lung disease
 Airway protection (aspiration/reflux)
 Airway Malacia
Discussion

Open lung biopsy?

Repeat bronchoscopy and BAL?
Outline





Case presentation: Cough, Hypoxia, and Down
Syndrome
Differential Diagnosis of Cough and Hypoxia
Multi-system complications of patients with
Trisomy 21
Evaluation for Elevated Iron Index and
Pulmonary Hypertension
Treatment and Monitoring of PAH
Thank you!
4
infants with acute pulmonnary
hemorrhage
stain first seen 50 hours –
5 days from event
Clearance in 1-2 weeks
Hemosiderin